Status:
RECRUITING
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
University of Utah
National Institute on Drug Abuse (NIDA)
Conditions:
Polysubstance Abuse
Opioid Use
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...
Eligibility Criteria
Inclusion
- English-speaking
- Age ≥18
- Currently on methadone; and 4) currently smoke cigarettes.
Exclusion
- Severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
- Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
- Inability to attend or fully participate in intervention sessions or assessments
- Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
- Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
- Any contraindications for NRT
- Currently or soon planning to be pregnant or breastfeeding.
Key Trial Info
Start Date :
September 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT06033599
Start Date
September 5 2023
End Date
June 30 2027
Last Update
February 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
2
University of Utah
Salt Lake City, Utah, United States, 84108